Lewy-body dementia and responsiveness to cholinesterase inhibitors: a paradigm for heterogeneity of Alzheimer's disease?
- 30 April 1996
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 17 (4) , 155-160
- https://doi.org/10.1016/0165-6147(96)81592-6
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Long-term protective effects of human recombinant nerve growth factor and monosialoganglioside GM1 treatment on primate nucleus basalis cholinergic neurons after neocortical infarctionNeuroscience, 1993
- Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primatesAnnals of Neurology, 1991
- Nerve growth factor and Alzheimer's diseaseAnnals of Neurology, 1986
- Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in alzheimer's diseaseNeuroscience, 1985
- The anatomy of the CNS cholinergic neuronsTrends in Neurosciences, 1984
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982
- Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal ForebrainScience, 1982
- SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASEPublished by Elsevier ,1976
- NEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIESBrain, 1976
- Human Memory and the Cholinergic SystemArchives of Neurology, 1974